Skip to content

Clearblue Advanced Fertility Monitor Consumer One Cycle at Home Study

Clearblue Advanced Fertility Monitor Consumer One Cycle at Home Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01948258
Enrollment
395
Registered
2013-09-23
Start date
2013-03-01
Completion date
2013-11-30
Last updated
2018-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Pregnancy

Brief summary

This study will assess the use of the new Clearblue Advanced Fertility Monitor for one menstrual cycle in a home setting by female volunteers seeking to get pregnant.

Detailed description

The Clearblue Fertility Monitor is a personal monitor designed to be used with disposable test sticks for the semi-quantitative measurement of estrone-3-glucuronide (E3G) and luteinising hormone (LH) in women's urine. This personal information allows women to identify their fertile window and appropriately time intercourse in order to maximise their chances of conception. A new version of this monitor (Clearblue Advanced Fertility Monitor) has been developed with additional functionality including the option to test for pregnancy. This study will assess the volunteer ease of use of the new Clearblue Advanced Fertility Monitor and the understanding and interpretation of the results by the user. This is a single centre clinical study which will be conducted by volunteers at their residence and co-ordinated by the clinical department at SPD Development Company Ltd. A minimum of 100 female volunteers representing the target consumer will be required to use the new Clearblue Advanced Fertility Monitor at home as per the instructions for use. This will involve them setting up the monitor, using the monitor for one full cycle and then setting up the monitor for their next cycle unless they test for pregnancy and get a pregnant result. At the end of one full cycle, all volunteers will complete a study questionnaire which includes sections on comprehension of the instructions for use, ease of use and interpretation of test results.

Interventions

DEVICEClearblue Advanced Fertility Monitor

Clearblue Advanced Fertility Monitor used for one menstrual cycle in a home setting

Sponsors

SPD Development Company Limited
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Female * Aged 18 - 45 years * Willing to provide written informed consent to participate in the study and comply to the investigational procedures * Naive to similar marketed products including current Clearblue fertility monitor and Persona * Two natural cycles immediately prior to entering the study, each lasting between 21 and 42 days * Seeking to become pregnant

Exclusion criteria

* Unwilling to provide written informed consent to participate in the study or comply with study procedures * Employees of SPD, Proctor & Gamble or Alere * Have a condition that is known to be contra-indicated in pregnancy * Usually have menstrual cycles which are shorter than 21 days or longer than 42 days * Using or have used in their last 2 cycles, hormonal contraceptives including oral, emergency oral, implants, patches, transdermal injections, vaginal ring and progesterone intrauterine systems (IUS) * Using or have used in the last 2 cycles, infertility medications or hormone replacement therapy containing hCG or LH * Taking clomiphene citrate or other ovulation induction drugs * Are using any treatment which may affect the menstrual cycle * Have recently been pregnant, miscarried or breastfeeding * Have been diagnosed with polycystic ovarian syndrome (PCOS) * Are peri- or post-menopausal e.g. experiencing symptoms such as irregular menstrual periods, hot flushes, night sweats, sleep disturbances and mood swings * Are taking antibiotics containing tetracyclines * Have impaired liver or kidney function * Have previously participated in a SPD 'trying to conceive' study

Design outcomes

Primary

MeasureTime frameDescription
The Ability of the Volunteer to Use the New Clearblue Advanced Fertility Monitoring a Home Settingone month useAcceptance criteria is that ≥80% of volunteers will score 3 or less on the Likert scale in a home setting by demonstrating ease of use and comprehension of the instructions for use.

Secondary

MeasureTime frameDescription
Correct Identification of Monitor Statusone monthTo demonstrate correct user identification of fertility status and test days and to determine the performance of the monitor in consumer hands.

Other

MeasureTime frameDescription
Pregnancy Test Resultone monthPregnancy test results will also be compared with both the performance of a currently marketed pregnancy test when used by a trained technician and quantitative hCG concentration.

Countries

United Kingdom

Participant flow

Recruitment details

This study was conducted by volunteers remotely and managed by the clinical department at SPD. For the study, 395 females aged between 18-45 years were recruited via internet advertising and from women who had participated in previous SPD studies. The first volunteer was recruited on 1st March 2013, the last was recruited on 1st August 2013.

Pre-assignment details

Volunteers were instructed to test for pregnancy prior to starting the study. If pregnant before the start of their cycle they were withdrawn and classified as a pre-study pregnancy. Volunteers were also withdrawn if identified as health care professionals.

Participants by arm

ArmCount
Fertility Monitor
Use of Clearblue Fertility Monitor
233
Total233

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyDid not complete by cut-off date35
Overall StudyHealth Care Professional43
Overall StudyLost to Follow-up27
Overall StudyPregnancy41
Overall StudyRemoved from statistical analysis2
Overall StudyWithdrawal by SPD8
Overall StudyWithdrawal by Subject6

Baseline characteristics

CharacteristicFertility Monitor
Age, Customized
Age of Participants
18-25
38 Participants
Age, Customized
Age of Participants
26-30
68 Participants
Age, Customized
Age of Participants
31-35
64 Participants
Age, Customized
Age of Participants
36-40
56 Participants
Age, Customized
Age of Participants
41-45
7 Participants
Highest qualification
A levels, vocational level 3 and equivalents (age
55 Participants
Highest qualification
Degree or equivalent (college degree)
77 Participants
Highest qualification
GCSE (Grade A*-C), vocational level 2 and equivale
41 Participants
Highest qualification
No qualifications
5 Participants
Highest qualification
Other higher education below degree level (associa
20 Participants
Highest qualification
Other qualifications
8 Participants
Highest qualification
Post-graduate qualifications
25 Participants
Highest qualification
Qualifications at level 1 and below
2 Participants
Occupation
Administrative / Secretarial
24 Participants
Occupation
Associate Professional / Technical
27 Participants
Occupation
Homemaker
32 Participants
Occupation
Managerial
23 Participants
Occupation
Manufacturing / Driver
0 Participants
Occupation
Other
12 Participants
Occupation
Personal Services
8 Participants
Occupation
Professional
59 Participants
Occupation
Sales / Customer Services
29 Participants
Occupation
Skilled Trade
4 Participants
Occupation
Student
4 Participants
Occupation
Support Personnel
11 Participants
Race/Ethnicity, Customized
Race/Ethnicity
American Indian or Alaska Native
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : Bangladeshi
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : Chinese
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : Indian
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : Other Asian
2 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : Pakistani
6 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Asian : South Asian
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black: African
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black: Caribbean
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Black: Other Black
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Mixed
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
Native Hawaiian or other Pacific Islander
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: American
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: Australian/New Zealander
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: Eastern European
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: Mediterranean/Middle Eastern
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: Other White
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity
White: Western European
210 Participants
Sex: Female, Male
Female
233 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 393
other
Total, other adverse events
0 / 393
serious
Total, serious adverse events
0 / 393

Outcome results

Primary

The Ability of the Volunteer to Use the New Clearblue Advanced Fertility Monitoring a Home Setting

Acceptance criteria is that ≥80% of volunteers will score 3 or less on the Likert scale in a home setting by demonstrating ease of use and comprehension of the instructions for use.

Time frame: one month use

Population: Volunteers whose data contributes to the full analysis set.

ArmMeasureValue (NUMBER)
Fertility MonitorThe Ability of the Volunteer to Use the New Clearblue Advanced Fertility Monitoring a Home Setting89.7 percentage of participants
Secondary

Correct Identification of Monitor Status

To demonstrate correct user identification of fertility status and test days and to determine the performance of the monitor in consumer hands.

Time frame: one month

Population: Volunteers who completed the study, who had daily diary entries and monitor download data for days on which a test was conducted

ArmMeasureValue (NUMBER)
Fertility MonitorCorrect Identification of Monitor Status91.2 percentage of participants
Other Pre-specified

Pregnancy Test Result

Pregnancy test results will also be compared with both the performance of a currently marketed pregnancy test when used by a trained technician and quantitative hCG concentration.

Time frame: one month

Population: Volunteers who completed the study, comparison of Clearblue Fertility Monitor pregnancy test results and a marketed pregnancy test. Results for all tests conducted.

ArmMeasureGroupValue (NUMBER)
Fertility MonitorPregnancy Test ResultMonitor test result in agreement with predicate99.3 percentage of tests in agreement
Fertility MonitorPregnancy Test ResultMonitor test result in agreement with hCG levels100 percentage of tests in agreement

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026